Halozyme Therapeutics to Present at Two Upcoming Investor Conference... ( SAN DIEGO March 7 2012 /- Haloz...)

Halozyme Therapeutics to Present at Two Upcoming Investor Conferences in March

Date:3/7/2012

SAN DIEGO, March 7, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the following two investor conferences in March:

24^th Annual Roth Conference in Dana Point on March 14, 2012 at 12:30 p.m. ET/9:30 a.m. PT. Kurt Gustafson, Chief Financial Officer of Halozyme Therapeutics, will provide a corporate overview.
Barclays Capital 2012 Global Healthcare Conference in Miami on March 14, 2012 at 4:15 p.m. ET/1:15 p.m. PT. Gregory I. Frost, Ph.D., President and Chief Executive Officer of Halozyme Therapeutics, will provide a corporate overview.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

The presentations will be webcast through the "Investors" section of Halozyme's corporate website at www.halozyme.com, and recordings will be made available for 90 days following the events. To access the live webcasts, please log on to Halozyme's website approximately fifteen minutes prior to the presentations to register and download any necessary audio software.

About Halozyme
Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, that increase the absorption and dispersion of biologics. Halozyme's pipeline addresses therapeutic areas, such as diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Baxter, ViroPharma and Intrexon. Halozyme is headqua
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Halozyme to Host Fourth Quarter and 2011 Year-End Financial Results Conference Call
2. Halozyme Therapeutics to Present at the 30th Annual J.P. Morgan Healthcare Conference
3. Halozyme Therapeutics Reports Third Quarter 2011 Financial Results
4. Halozyme Therapeutics Announces Data From Two Phase 1 Studies of PEGPH20 Demonstrating Targeting of Hyaluronan in Tumor Stroma
5. Halozyme Begins Clinical Trial with HTI-501 in Women with Edematous Fibrosclerotic Panniculopathy
6. Halozyme Therapeutics to Present at the JMP Securities Healthcare Conference on September 28
7. Halozyme Therapeutics to Present Data on its Ultrafast Insulin Programs at the Upcoming American Diabetes Association 71st Scientific Sessions
8. Halozyme Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference on June 9
9. Halozyme Therapeutics Reports First Quarter 2011 Financial Results
10. Halozymes Ultrafast Insulin Generates Faster-In and Faster-Out Profile for Type 1 Diabetes Patients Using Insulin Pumps
11. Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial With Subcutaneous MabThera® (rituximab)

Post Your Comments:

(Date:2/27/2015)... CAMBRIDGE, Mass. , Feb. 27, 2015 /PRNewswire-USNewswire/ ... Analysis of the NCATS rare-diseases portfolio " in ... of a new financing technique to reduce the ... new diseases and potentially unlock new levels of ... The product of a unique collaboration between ...

(Date:2/27/2015)... Australia , Feb. 27, 2015 Bionomics ... from the DisrupTOR-1 trial of BNC105 in patients with ... in Orlando, Florida . The data ... of the City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and ...

(Date:2/27/2015)... , Feb. 27, 2015 Steep Hill, the ... US and internationally, intends to open a full service ... New Mexico , bringing advanced scientific tools and ... Steep Hill is currently the only laboratory ... conduct potency and contaminant testing in order to meet ...

(Date:2/26/2015)... 2015 23andMe, the leading personal genetics company, today ... Privacy Officer and Corporate Counsel. Black brings a strong ... well as health care regulations. As a member of ... for reviewing, updating and enhancing the company,s privacy and ... She joined the company January 5, 2015 and reports ...

Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2 New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3 New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4 New BNC105 Biomarker Data to be Presented at US Cancer Conference 2 New BNC105 Biomarker Data to be Presented at US Cancer Conference 3 New BNC105 Biomarker Data to be Presented at US Cancer Conference 4 New BNC105 Biomarker Data to be Presented at US Cancer Conference 5 Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 2 23andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2

[0] New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases [0] New BNC105 Biomarker Data to be Presented at US Cancer Conference [0] Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico [0] 23andMe Appoints Kate Black as Privacy Officer and Corporate Counsel

... by nature,s ability to shape a petal, and building ... at the University of Massachusetts Amherst have developed a ... to aid advances in biomedicine, robotics and tunable micro-optics. ... their new method of halftone gel lithography for photo-patterning ...

... few years ago following the discovery of the DNA ... nanoparticles of a given shape and size. However, real ... international team of researchers led by Professor Tim Liedl ... the Technische Universitaet Muenchen have now succeeded in building ...

... that examines a new type of silicon-carbon nanocomposite ... how repeated use could wear them down. The ... performs better than silicon alone. With an electrical ... electrodes, silicon-carbon nanocomposite electrodes could lead to longer-lasting, ...

Cached Biology Technology:UMass Amherst polymer scientists, physicists develop new way to shape thin gel sheets 2 UMass Amherst polymer scientists, physicists develop new way to shape thin gel sheets 3 Nano spiral staircases modify light 2 Silicon-carbon electrodes snap, swell, don't pop 2 Silicon-carbon electrodes snap, swell, don't pop 3 Silicon-carbon electrodes snap, swell, don't pop 4

UMass Amherst polymer scientists, physicists develop new way to shape thin gel sheets Nano spiral staircases modify light Silicon-carbon electrodes snap, swell, don't pop

(Date:2/10/2015)... Feb. 10, 2015 Alere Inc. (NYSE: ALR), ... financial results for the quarter ended December 31, ... and President of Alere said, "We made substantial ... as the global leader in rapid diagnostics and ... Alere Health divestiture in early January enabled us ...

(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... website ( http://www.nxt-id.com/ ) as part of its 2015 ... The Company launched its new consumer website for Wocketwallet.com ... , CEO of NXT-ID said, "Our new corporate website ...

(Date:2/5/2015)... Calif. , Jan. 30, 2015 It is ... great power and potential for genomic science as a ... in disease prevention and treatment. I was honored to ... new, government-funded precision medicine program. Since ... the science of genomics—from the first sequenced genome of ...

[1] Alere Inc. Announces Fourth Quarter 2014 Results [0] NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet [0] J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event

... of folic acid supplements appears to lower blood levels of ... heart and blood vessel diseasebut does not appear to be ... over a five-year period, according to a meta-analysis of previously ... of Internal Medicine , one of the JAMA/Archives journals. ...

... home alone, and they show it by barking, destroying things, ... October 12th issue of Current Biology, a Cell ... most often in dogs that also show "pessimistic"-like behavior. ... people are more likely to judge an ambiguous situation positively," ...

... EDITOR,S PICK: Intriguing viral link to intestinal cancer in mice ... States test positive for human cytomegalovirus (HCMV) infection. For most ... persisting in the body for a long time. HCMV infects ... line the intestines (IECs). New research, led by Sergio Lira, ...

Cached Biology News:Meta-analysis shows no heart benefits for folic acid supplements 2 Meta-analysis shows no heart benefits for folic acid supplements 3 Dogs' anxiety reflects a 'pessimistic' mood 2 JCI online early table of contents: Oct. 11, 2010 2 JCI online early table of contents: Oct. 11, 2010 3 JCI online early table of contents: Oct. 11, 2010 4 JCI online early table of contents: Oct. 11, 2010 5 JCI online early table of contents: Oct. 11, 2010 6 JCI online early table of contents: Oct. 11, 2010 7

Meta-analysis shows no heart benefits for folic acid supplements Dogs' anxiety reflects a 'pessimistic' mood JCI online early table of contents: Oct. 11, 2010

Request Info...

... Certified USDA Research Registered OLAW Assured AAALAC ... AALAS Certified Technicians Documentation ... Upon Request Focus CRP is ... your custom immunology service needs. We ...

Request Info...

Biology Products:

Tramadol ELISA Kit, Single from Bio-Quant Inc.Isotyping from Covance Research Products, Inc Dengue Virus IgM ELISA Kit, Single from Bio-Quant Inc.THC ELISA Kit, Single from Bio-Quant Inc.